From a strategically curated pipeline of high-impact
generics to proven market leaders, every Aryeh product
delivers uncompromising quality, broad accessibility, and
meaningful therapeutic value, closing critical gaps in
patient care where it matters most.
Strategic Product Engine: Global Muscle, U.S. Mindset
IN-HOUSE DEVELOPMENT
High-impact therapies have been developed where control,
quality, and differentiation matter most.
IN-LICENSING
Proven, market-ready products to accelerate entry and expand
portfolio breadth.
STRATEGIC PARTNERSHIPS
Collaborations with top-tier CDMOs for lean, scalable, and
reliable supply chains.
Advancing Our Development Pipeline
Expanding our portfolio with innovative solutions across key therapeutic areas.
25+
In Development
Products advancing across all therapeutic categories
15
Clinical Trials
Active bioequivalence and pivotal studies are underway
8
FDA Review
Submissions currently under regulatory evaluation
2026
Next Launch
Upcoming product approvals and market entries
Need Help?
Looking for Specific Product Details?
Connect with our team for product specifications, regulatory
documents, and partnership opportunities, everything you
need to make informed decisions and deliver exceptional
patient care.
